Michael Lutz
Advisory Board
cytena
Germany
Biography
Early 2014 cytena appointed Dr. Michael Lutz, an experienced biotech entrepreneur, as advisor for strategic and business planning . Dr. Lutz has extensive experience in the development and management of biotech companies. Since 2005, Dr. Lutz has successfully built up six biotech companies and raised funding well over 10 million EUR. Three of these companies were sold to publicly traded biotech companies. His current focus is in the area of prenatal diagnosis where he acts as CEO of LifeCodexx AG since 2010. Before 2005 Dr. Lutz spent many years working in various management positions at Novartis Pharma and Evotec.
Research Interest
Biotechnology
